Forbion Capital Partners today announced the appointment of Dr Kapil Dhingra, formerly global leader in oncology at Roche, and Prof. John Kastelein, Professor of Medicine at the Department of Vascular Medicine at the University of Amsterdam, as Scientific Advsors. They will be advising on oncology and metabolic disease investment opportunies respectively.